We proceeded to explore whether there were any correlations between plasma versican or plasma exosomal versican levels and distant metastases (e.g., brain, bone) or mutation(e.g., EGFR, ALK) in NSCLC patients. Here, ALK is linked to non-small cell lung carcinoma.